Tract Bio Unveils Key to CF Lung Inflammation
Tract Bio, a biotechnology company focused on developing therapies for cancer and inflammatory diseases, has recently announced a significant publication in the American Journal of Respiratory and Critical Care Medicine. The publication details their research on stem cell variants that contribute to chronic lung inflammation in cystic fibrosis patients treated with CFTR modulators. Key Highlights […]
Revolutionizing Cystic Fibrosis: DNA Tech Breakthrough
Moligo Technologies has entered into a collaboration with Nationwide Children’s Hospital to provide long, single-stranded DNA (ssDNA) for research into gene therapies for cystic fibrosis (CF) and other airway diseases. Moligo’s innovative enzymatic DNA production technology produces ultrapure, long ssDNA at an industrial scale. This technology is especially promising as it can introduce chemical modifications, […]